natural

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

1. 43/100

   Antibody-Mediated Clearance of Brain Amyloid-β: Mechanisms of Action, Effects of Natural and Monoclonal Anti-Aβ Antibodies, and Downstream Effects

   ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Journal of Alzheimer's disease reports · 2023-08-14 · Treatments

   Immunotherapeutic efforts to slow the clinical progression of Alzheimer's disease (AD) by lowering brain amyloid-β (Aβ) have included Aβ vaccination, intravenous immunoglobulin (IVIG) products, and anti-Aβ monoclonal antibodies.

   • Treatments
   • Brain Biology
2. 40/100

   "Therapeutic uses of natural astaxanthin: An evidence-based review focused on human clinical trials"

   ✓ Peer-reviewed alzhub usefulness score 40 out of 100. Pharmacological research · 2021-02-04 · Brain scans and imaging

   Astaxanthin is a natural C40 carotenoid with numerous reported biological functions, most of them associated with its antioxidant and anti-inflammatory activity, standing out from other antioxidants as it has shown the highest oxygen radical absorbance capacity (ORAC), 100-500 times higher than ⍺-tocopherol and a 10 times higher free radical inhibitory activity than related antioxidants (α-tocopherol, α-carotene, β -carotene, lutein and lycopene).

   • Treatments
   • Clinical Trials
3. 36/100

   Identification and characterization of natural antibodies against tau protein in an intravenous immunoglobulin product

   ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Journal of neuroimmunology · 2015-10-28 · Drug development

   The latest therapeutic approaches to Alzheimer disease are using intravenous immunoglobulin (IVIG) products.

   • Brain Biology
4. 43/100

   Argyrophilic grain pathology as a natural model of tau propagation

   ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Journal of Alzheimer's disease : JAD · 2014-01-01 · Drug development

   Argyrophilic grain disease (AGD) is a sporadic 4 R tauopathy that usually presents in combination with other sporadic tauopathies or with Alzheimer's disease (AD) pathology, and may contribute to dementia in older age patients.

   • Genetics
5. 36/100

   Alzheimer disease susceptibility loci: evidence for a protein network under natural selection

   ✓ Peer-reviewed alzhub usefulness score 36 out of 100. American journal of human genetics · 2012-04-01 · Genetics

   Recent genome-wide association studies have identified a number of susceptibility loci for Alzheimer disease (AD).

   • Genetics

All topic tags with their study counts